fr   en
Agreement

Tableaux synoptiques (en anglais)


Parcourir par date
Rechercher par mot clé
Date: 2006-01-23
Biotech partner: Biovitrum (Sweden)
Pharma Partner: Syntonix (USA)
Type of agreement: * commercialization/ distribution
* development
Compound: recombinant factor IX
Disease area: haemophilia B
Development phase:  
Nature of the agreement:  
Financial terms of the agreement: details not disclosed


Go back to previous page